Elthera
Zurich, Switzerland· Est. 2017
Precision medicine treatments for patients with highly aggressive malignancies.
Private Company
Total funding raised: $25.2M
About
Precision medicine treatments for patients with highly aggressive malignancies.
Cell & Gene Therapy
Funding History
2Total raised:$25.2M
Series A$22MNov 15, 2022
Seed$3.2MSep 15, 2020